Evidence map›Paper›PMID 31658044›Full record

ArticleCancer biomarkers : section A of Disease markers2019

Low expression of KIF7 indicates poor prognosis in epithelial ovarian cancer.

Yaoshan Yao, Longyang Liu, Wenhua He, Xian Lin, Xuan Zhang, Zhongqiu Lin, Zhaoyang Zeng, Suiqun Guo

Abstract read
In one paragraph

Article in Cancer biomarkers : section A of Disease markers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Expression and clinical value of EIF3CL in serous ovarian cancer.The Journal of international medical research · 2025
    Article
  4. Disulfidptosis in tumor progression.Cell death discovery · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Fly · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. FOXO1 overexpression is correlated with poor prognosis in epithelial ovarian cancer.Cancer biomarkers : section A of Disease markers · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Yaoshan YaoDepartment of Obstetrics and Gynecology, Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Longyang LiuDepartment of Gynecology, Integrated Hospital of Traditional Chinese Medicine, Southern Medical Universtiy, Guangzhou, Guangdong, China.
Wenhua HeDepartment of Cardiovascular Medicine, First People's Hospital of Chenzhou, Hunan, China.
Xian LinDepartment of Oncology, Fujian Provincial Cancer Hospital, Fuzhou, Fujian, China.
Xuan ZhangDepartment of Gynecology Oncology, First People's Hospital of Chenzhou, Chenzhou, Hunan, China.
Zhongqiu LinDepartment of Gynecology Oncology, The Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Zhaoyang ZengDepartment of Gynecology, Integrated Hospital of Traditional Chinese Medicine, Southern Medical Universtiy, Guangzhou, Guangdong, China.
Suiqun GuoDepartment of Obstetrics and Gynecology, Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Chenzhou First People's Hospital · CNTCM-Intigrated Cancer Center of Southern Medical University · CNThird Affiliated Hospital of Southern Medical University · CNFujian Provincial Cancer Hospital · CNSun Yat-sen Memorial Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to investigate kinesin family member 7 (KIF7) expression in epithelial ovarian cancer tissues (paraffin-embedded tissues and fresh) and to explore its expression, association with clinicopathological parameters and prognostic value in patients with epithelial ovarian cancer. A total of 113 paraffin-embedded tumor tissues of epithelial ovarian cancer patients diagnosed and operated at the memorial hospital of Sun Yat-sen University Between December 2009 and March 2017 and 41 paratumor tissues were collected for the present study and were assessed for KIF7 expression using immunohistochemistry. Furthermore, 22 fresh epithelial ovarian cancer tissues and their matched paratumor tissues were collected from the Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, between August 2013 and March 2019 and subjected to reverse-transcription quantitative PCR analysis to detect the mRNA expression of KIF7. The expression of KIF7 was lower in cancer tissues than in paratumor tissues, and KIF7 expression was associated with recurrence-free survival and overall survival in epithelial ovarian cancer patients. Furthermore, multivariate logistic regression analysis indicated that low KIF7 expression was an independent predictor of poor survival in patients with epithelial ovarian cancer. In conclusion, KIF7 has a tumor suppressor role in epithelial ovarian cancer and is a useful independent prognostic predictor. It may hold important value for the clinical diagnosis and treatment of epithelial ovarian cancer.

Indexed as

Carcinoma, Ovarian EpithelialFemaleHumansImmunohistochemistryKinesinsMiddle AgedPrognosisSurvival AnalysisKIF7 protein, humanKinesinsepithelial ovarian cancerimmunohistochemistrykinesin family member 7prognosisreverse-transcription quantitative PCR

Identifiers

PMID31658044
PMCPMC12826400
OpenAlexW2981924266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.